EZH2 inhibition offers hope for fighting treatment-resistant cancers
The critical role of EZH2, an essential epigenetic regulator, in cancer progression and treatment is underscored in this new review ...
Tag: Lymphoma
Future of cancer coverage for women federal firefighters uncertain under Trump
It took nearly three years to win presumptive workers' compensation coverage for breast, cervical, and other cancers that firefighters who ...
The CAR T Veteran: A Journey of Resilience, Remission, and Advocacy
Laurie Adami has an extraordinary story. After a 12-year battle with stage IV Follicular Non-Hodgkin Lymphoma, Laurie found her path to ...
Breakthrough in gene-editing with Cas12a for modeling human diseases
Australian cancer researchers are the first to establish a next-generation gene-editing tool for modeling and interrogating human disease. A novel ...
LGBTQ+ people relive old traumas as they age on their own
Bill Hall, 71, has been fighting for his life for 38 years. These days, he's feeling worn out. Hall contracted ...
UC's Eric Vick receives major grants to advance research into combination therapy for leukemia
The University of Cincinnati Cancer Center's Eric Vick, MD, PhD, has been awarded a nearly $215,000 Career Development Award from ...
EZH2's role in cancer progression and therapy explored
Enhancer of zeste homolog 2 (EZH2) is a catalytic subunit of the Polycomb-repressive complex 2 (PRC2), which plays a crucial ...
CD5 knockout using CRISPR boosts CAR T cell therapy efficacy
The effectiveness of CAR T cell therapy against a variety of cancers, including solid tumors, could be boosted greatly by ...
CD22-targeted CAR-T therapy shows promising results in relapsed large B-cell lymphoma
CAR-T cell therapy, which targets a specific protein on the surface of cancer cells, causes tumors to shrink or disappear ...
Tattoos linked to higher risk of malignant lymphoma, study finds
In a recent study published in the journal eClinicalMedicine, researchers determined the relationship between tattoo ink exposure and malignant lymphoma ...